ID: ALA5206047

Max Phase: Preclinical

Molecular Formula: C28H28N6O5S

Molecular Weight: 560.64

Associated Items:

Representations

Canonical SMILES:  CNC(=O)[C@@]12C[C@@H]1[C@@H](n1cnc3c(NCCc4ccc(O)c(OC)c4)nc(C#Cc4ccsc4)nc31)[C@H](O)[C@@H]2O

Standard InChI:  InChI=1S/C28H28N6O5S/c1-29-27(38)28-12-17(28)22(23(36)24(28)37)34-14-31-21-25(30-9-7-15-3-5-18(35)19(11-15)39-2)32-20(33-26(21)34)6-4-16-8-10-40-13-16/h3,5,8,10-11,13-14,17,22-24,35-37H,7,9,12H2,1-2H3,(H,29,38)(H,30,32,33)/t17-,22-,23+,24+,28+/m1/s1

Standard InChI Key:  FICOFRMVEIYFPN-CIZVZKTGSA-N

Associated Targets(Human)

Adenosine A1 receptor 17603 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Adenosine A2a receptor 16305 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Adenosine A3 receptor 15931 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Adenosine A1 receptor 162 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Adenosine A3 receptor 257 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 560.64Molecular Weight (Monoisotopic): 560.1842AlogP: 1.69#Rotatable Bonds: 7
Polar Surface Area: 154.65Molecular Species: NEUTRALHBA: 11HBD: 5
#RO5 Violations: 2HBA (Lipinski): 11HBD (Lipinski): 5#RO5 Violations (Lipinski): 2
CX Acidic pKa: 10.23CX Basic pKa: 3.41CX LogP: 2.23CX LogD: 2.23
Aromatic Rings: 4Heavy Atoms: 40QED Weighted: 0.21Np Likeness Score: -0.09

References

1. Tosh DK, Salmaso V, Campbell RG, Rao H, Bitant A, Pottie E, Stove CP, Liu N, Gavrilova O, Gao ZG, Auchampach JA, Jacobson KA..  (2022)  A3 adenosine receptor agonists containing dopamine moieties for enhanced interspecies affinity.,  228  [PMID:34844790] [10.1016/j.ejmech.2021.113983]

Source